 "Dr Reddy's Labs gains as Srikakulam SEZ Unit II get EIR from USFDA")
Dr Reddy’s Laboratories moved higher by nearly 7% to Rs 2,466 on BSE in an otherwise weak market after the company received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (US-FDA), for its formulation facility at Srikakulam plant (SEZ) Unit II, Andhra Pradesh.
On May 25, 2017, the company said that USFDA had made the audit of the Unit II formulations facility with zero observations.
Upon completion of an inspection, an EIR is written which details inspectional findings.
At 10:18 am, the stock was up 5% at Rs 2,425 on BSE, against 0.52% decline in the S&P BSE Sensex. The trading volumes on the counter nearly doubled with a combined 1.56 million shares changed hands on the NSE and BSE so far.
On May 25, 2017, the company said that USFDA had made the audit of the Unit II formulations facility with zero observations.
Upon completion of an inspection, an EIR is written which details inspectional findings.
At 10:18 am, the stock was up 5% at Rs 2,425 on BSE, against 0.52% decline in the S&P BSE Sensex. The trading volumes on the counter nearly doubled with a combined 1.56 million shares changed hands on the NSE and BSE so far.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%